CLAIRE WISWALL: Open Payments
NPI 1164501649 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 22 payments from 12 companies in 2025. Trend: 2023 $1,202 · 2024 $708 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $89 |
| Amgen Inc. | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| ABBVIE INC. | 1 | $56 |
| LEO Pharma Inc. | 2 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
| Janssen Biotech, Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Incyte Corporation | 1 | $25 |
Products named: DUPIXENT, Otezla, BOTOX, ILUMYA, TREMFYA, ANZUPGO, TALTZ, COSENTYX.
Industry payments across CA — which companies pay providers there.
